Conference call highlights. -42% global revenue growth -first full quarter of positive cash flow -first full six months of positive cash flow -good position to expand in the aortic stent graft market -sales force expanding and taking market share -still plenty of opportunity for further growth -2010 international market will be expanded into -record revenue 13.2m in quarter -gross margin improvements from volume efficiencies -increase in cash balance -raised revenue guidance -IntuiTrac has an advantage in ease of use and expansion with new physicians -competitors are Medtronic, W. L. Gore & Associates and Cook Group Inc.-but their devices are bigger and the smaller device of endologix has an advantage -8% yearly procedure growth All great news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.